ApprovalTrail

Medical device licence · 36845 · Class 2

HDL-CHOLESTEROL

No longer licensed: discontinued at renewal

Licence status Discontinued at renewal; first licensed March 18, 2002; ended October 13, 2020. It is in Health Canada’s archive of licences no longer in force.
Licence number
36845
Licence holder
Randox Laboratories Ltd.Crumlin, AT, United Kingdom
Risk class
Class II (low to moderate risk)
Licence type
Test Kit
First licensed
March 18, 2002
Ended
October 13, 2020
Devices covered
9

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • DIRECT HDL CHOLESTEROL (HDL) HITACHI 917, HITACHI MODULAR P
  • DIRECT HDL-CHOLESTEROL (LIQUID) CLEAR. METHOD, COBAS/HITACHI/SYNCHRON CX/LX
  • DIRECT HDL-CHOLESTEROL CLEARANCE METHOD HITACHI 737/747, HITACHI MODULAR D
  • DIRECT HDL-CHOLESTEROL CLEARANCE METHOD, DIMENSION
  • DIRECT HDL-CHOLESTEROL CLEARANCE METHOD, HITACHI 747
  • DIRECT HDL-CHOLESTEROL CLEARANCE METHOD, RX DAYTONA
  • DIRECT HDL-CHOLESTEROL CLEARANCE METHOD, SYNCHRON CX/LX
  • DIRECT HDL-CHOLESTEROL PEGME METHOD AUTO. & MANUAL HITACHI/SYNCHRON CX/LX
  • HDL-CHOLESTEROL (LIQUID) PHOSPHOTUNG METHOD, GENERIC

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.